RARRES1

Chr 3

retinoic acid receptor responder 1

Also known as: LXNL, PERG-1, TIG1

This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
0
Active trials
28
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.61
LOEUF
—
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.61LOEUF
pLI 0.000
Z-score -0.08
OE 1.02 (0.67–1.61)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.82Z-score
OE missense 0.79 (0.67–0.94)
98 obs / 123.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?1.02 (0.67–1.61)
0≤0.351.4
Missense OE?0.79 (0.67–0.94)
0≤0.61.4
Synonymous OE?0.83
0≤1.21.6
LoF obs/exp: 13 / 12.7Missense obs/exp: 98 / 123.8Syn Z: 0.88

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

RARRES1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →